177 related articles for article (PubMed ID: 22743590)
1. Tebrophen--an old polyphenol drug with anticancer potential.
Rubelj I; Stepanić V; Jelić D; Vidaček NŠ; Kalajžić AĆ; Ivanković M; Nujić K; Matijašić M; Verbanac D
Molecules; 2012 Jun; 17(7):7864-86. PubMed ID: 22743590
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of antitumor dendritic imides.
Braña MF; Domínguez G; Sáez B; Romerdahl C; Robinson S; Barlozzari T
Bioorg Med Chem Lett; 2001 Dec; 11(23):3027-9. PubMed ID: 11714603
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica.
Nguyen PH; Le TV; Thuong PT; Dao TT; Ndinteh DT; Mbafor JT; Kang KW; Oh WK
Bioorg Med Chem Lett; 2009 Dec; 19(23):6745-9. PubMed ID: 19836230
[TBL] [Abstract][Full Text] [Related]
5. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A
Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146
[TBL] [Abstract][Full Text] [Related]
6. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
8. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid.
Kahnberg P; Lucke AJ; Glenn MP; Boyle GM; Tyndall JD; Parsons PG; Fairlie DP
J Med Chem; 2006 Dec; 49(26):7611-22. PubMed ID: 17181145
[TBL] [Abstract][Full Text] [Related]
10. Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery.
Sakle NS; More SA; Dhawale SA; Mokale SN
Curr Drug Discov Technol; 2020; 17(5):585-615. PubMed ID: 31393251
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumour activity of new dendritic polyamines-(imide-DNA-intercalator) conjugates: potent Lck inhibitors.
Braña MF; Domínguez G; Sáez B; Romerdahl C; Robinson S; Barlozzari T
Eur J Med Chem; 2002 Jul; 37(7):541-51. PubMed ID: 12126773
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
14. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones.
Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926
[TBL] [Abstract][Full Text] [Related]
15. Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells.
Shin SY; Jung H; Ahn S; Hwang D; Yoon H; Hyun J; Yong Y; Cho HJ; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2014 Mar; 22(6):1809-20. PubMed ID: 24565968
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study.
El-Khouly OA; Henen MA; El-Sayed MA; Shabaan MI; El-Messery SM
Bioorg Med Chem; 2021 Feb; 31():115976. PubMed ID: 33388654
[TBL] [Abstract][Full Text] [Related]
18. Fine-tuning of substrate preferences of the Src-family kinase Lck revealed through a high-throughput specificity screen.
Shah NH; Löbel M; Weiss A; Kuriyan J
Elife; 2018 Mar; 7():. PubMed ID: 29547119
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based design, synthesis and biological studies of N⁵-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents.
Zhang Z; Tian C; Zhou S; Wang W; Guo Y; Xia J; Liu Z; Wang B; Wang X; Golding BT; Griff RJ; Du Y; Liu J
Eur J Med Chem; 2012 Dec; 58():228-36. PubMed ID: 23124219
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and scavenging radicals activities of some polyphenols related to dehydroabietylamine derivatives.
Liu CX; Lin ZX; Lu Z; Wang YM; Bao YL
J Asian Nat Prod Res; 2013; 15(8):819-27. PubMed ID: 23952738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
